|
Q2 FY2022
As of Jul 31, 2021
|
Q1 FY2022
As of Apr 30, 2021
|
Q4 FY2021
As of Jan 31, 2021
|
Q3 FY2021
As of Oct 31, 2020
|
Q2 FY2021
As of Jul 31, 2020
|
Q1 FY2021
As of Apr 30, 2020
|
Q4 FY2020
As of Jan 31, 2020
|
Q3 FY2020
As of Oct 31, 2019
|
Q2 FY2020
As of Jul 31, 2019
|
Q1 FY2020
As of Apr 30, 2019
|
Q4 FY2019
As of Jan 31, 2019
|
Q3 FY2019
As of Oct 31, 2018
|
Q2 FY2019
As of Jul 31, 2018
|
Q1 FY2019
As of Apr 30, 2018
|
Q4 FY2018
As of Jan 31, 2018
|
Q3 FY2018
As of Oct 31, 2017
|
Q2 FY2018
As of Jul 31, 2017
|
Q1 FY2018
As of Apr 30, 2017
|
Q4 FY2017
As of Jan 31, 2017
|
Q3 FY2017
As of Oct 31, 2016
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Redeemable noncontrolling interest payable | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Liabilities, Total | ||||||||||||||||||||
| Commitments and contingencies (see Note 11) | ||||||||||||||||||||
| Redeemable noncontrolling interest | ||||||||||||||||||||
| Shareholders' equity | ||||||||||||||||||||
| Common stock, $1 par value, authorized shares 100,000; issued 67,583 and 67,533, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Treasury stock at cost, 31,665 and 31,665 shares, respectively | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| Stockholders' Equity, Number of Shares, Par Value and Other Disclosures | ||||||||||||||||||||
| Common stock, par value (in dollars per share) | ||||||||||||||||||||
| Common stock, shares authorized (in shares) | ||||||||||||||||||||
| Common stock, shares issued (in shares) | ||||||||||||||||||||
| Treasury Stock, Common, Shares | ||||||||||||||||||||
Loading...
